Abstract
We measured small intestinal permeability using a lactulose:mannitol sugar permeability test in a group of children with autism, with current or previous gastrointestinal complaints. Secondly, we examined whether children with autism had an abnormal glucagon-like peptide-2 (GLP-2) response to feeding. Results were compared with sibling controls and children without developmental disabilities. We enrolled 14 children with autism, 7 developmentally normal siblings of these children and 8 healthy, developmentally normal, unrelated children. Our study did not detect differences in these measures of gastrointestinal function in a group of children with autism.
Similar content being viewed by others
References
Ahearn, W. H., Castine, T., Nault, K., & Green, G. (2001). An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified. Journal of Autism and Developmental Disorders, 31(5), 505–511.
Blaxill, M. F. (2004). What’s going on? The question of time trends in autism. Public Health Reports, 119(6), 536–551.
Breslin, N. P., Nash, C., Hilsden, R. J., Hershfield, N. B., Price, L. M., Meddings, J. B., & Sutherland, L. R. (2001). Intestinal permeability is increased in a proportion of spouses of patients with Crohn’s disease. The American Journal of Gastroenterology, 96(10), 2934–2938.
Chakrabarti, S., & Fombonne, E. (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. The American Journal of Psychiatry, 162(6), 1133–1141.
Charman, T. (2002). The prevalence of autism spectrum disorders. Recent evidence and future challenges. European Child & Adolescent Psychiatry, 11(6), 249–256.
D’Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E., & Giardini, O. (1996). Abnormal intestinal permeability in children with autism. Acta Paediatrica, 85(9), 1076–1079.
Drucker, D. J. (2005). Biologic actions and therapeutic potential of the proglucagon-derived peptides. Nature Clinical Practice Endocrinology & Metabolism, 1(1), 22–31.
Erickson, C. A., Stigler, K. A., Corkins, M. R., Posey, D. J., Fitzgrald, J. F., & McDougle, C. J. (2005). Gastrointestinal factors in autistic disorder: A critical review. Journal of Autism and Developmental Disorders, 35(6), 713–727.
Estall, J. L., & Drucker, D. J. (2006). Glucagon-like Peptide-2. Annual Review of Nutrition, 26, 391–411.
Field, D., Garland, M., & Williams, K. (2003). Correlates of specific childhood feeding problems. Journal of Paediatrics and Child Health, 39(4), 299–304.
Furlano, R. I., Anthony, A., Day, R., Brown, A., & McGarvey, L. et al. (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. The Journal of Pediatrics, 138(3), 366–372.
Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. The Journal of Pediatrics 135(5), 559–563.
Horvath, K., Zielke, R. H., Collins, R. M., Rabsztyn, A., Medeiros, L. A., & Perman, J. (2000). Secretin improves intestinal permeability in autistic children. Journal of Pediatric Gastroenterology Nutrition, 31, S31.
James, M. W., & Scott, B. B. (2000). Endomysial antibody in the diagnosis and management of coeliac disease. Postgraduate Medical Journal, 76(898), 466–468.
Kuddo, T., & Nelson, K. B. (2003). How common are gastrointestinal disorders in children. Current Opinion in Pediatrics, 15, 339–343.
Liu, Z., & Neu, J. (2005). Tight junctions, leaky intestines, and pediatric diseases. Acta Pediatrica., 94(4), 386–393.
Marsilio, R., D’Antiga, L., Zancan, L., Dussini, N., & Zacchello, F. (1998) Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clinical Chemistry, 44, 1685–1691.
Martin, G. R., Wallace, L. E., & Sigalet, D. L. (2004). Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. American Journal of Physiology. Gastrointestinal and Liver Physiology, 286(6), G964–G972.
Martin, G. R., Beck, P. L., & Sigalet, D. L. (2006). Gut hormones, and short bowel syndrome: The enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World Journal of Gastroenterology, 12(26), 4117–4129.
May, G. R., Sutherland, L. R., & Meddings, J. B. (1993). Is small intestinal permeability really increased in relatives of patients with Crohn’s disease? Gastroenterology, 104(6), 1627–1632.
Meddings, J. B., Sutherland, L. R., & May, G. R. (1994). Intestinal permeability in patients with Crohn’s disease. Gut, 35(11), 1675–1676.
Meddings, J. B. (1997). Review article: Intestinal permeability in Crohn’s disease. Alimentary Pharmacology & Therapeutics, 11(Suppl 3), 47–53 (discussion 53–56).
Molloy, C. A., & Manning-Courtney, P (2003). Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism, 7(2), 165–171.
Murphy, M. S., Eastham, E. J., Nelson, R., Pearson, A. D. J., & Laker, M. F. (1989) Intestinal permeability in Crohn’s Disease. Archives of Disease in Childhood, 64, 321–325.
Raiten, D. J., & Massaro, T. (1986). Perspectives on the nutritional ecology of autistic children. Journal of Autism and Developmental Disorders, 16(2), 133–143.
Rice, C., (2007) Prevalence of autism spectrum disorders–Autism and developmental disabilities monitoring network, 14 Sites, United States, 2002. MMWR Surveillance Summaries, 56 (SS01); 12–28.
Shattock, P., & Whiteley, P. (2002). Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opinion on Therapeutic Targets, 6(2), 175–183.
Sigalet, D. L., Martin, G., Meddings, J., Hartman, B., & Holst, J. J. (2004). GLP-2 levels in infants with intestinal dysfunction. Pediatric Research, 56(3), 371–376.
Sigalet, D. L., Bawazir, O., Martin, G. R., Wallace, L. E., Zaharko, G., Miller, A., & Zubaidi, A. (2006). Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Digestive Diseases and Sciences, 51(9), 1557–1566.
Topstad, D., Martin, G., & Sigalet, D. (2001). Systemic GLP-2 levels do not limit adaptation after distal intestinal resection. Journal of Pediatric Surgery, 36(5), 750–754.
Torrente, F., Ashwood, P., Day, R., Machado, N., & Furlano, R. I. et al. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry, 7(4), 375–382.
Valicenti-McDermott, M., McVicar, A., Rapin, I., Wershil, B. K., Cohen, H., & Shinnar, S., (2006). Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. Journal of Developmental and Behavioral Pediatrics, 27, S128–S136.
Van Elburg, R. M., Uil, J. J., Mulder, C. J., & Heymans, H. S. (1993). Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut, 34, 354–357.
Van Elburg, R. M., Uil, J. J., Kokke, F. T., Mulder, A. M., van der Broek, W. G., Mulder, C. J., & Heymans, H. S. (1995). Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. Journal of Pediatric Gastroenterology Nutrition, 20, 184–188.
Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., & Casson, D. M., et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351(9103), 637–641.
Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., & Montgomery, S. M. et al. (2000). Enterocolitis in children with developmental disorders. The American Journal of Gastroenterology, 95(9), 2285–2295.
Wakefield, A. J., Puleston, J. M., Montgomery, S. M., Anthony, A., & O’Leary, J. J. et al. (2002). Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacology & Therapeutics, 16(4), 663–674.
Wakefield A. J., Ashwood P., Limb K., & Anthony, A. (2005). The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. European Journal of Gastroenterology & Hepatology, 17(8), 827–836.
Acknowledgements
We extend thanks to Laurie Wallace, Cathy Osadetz, Sue Smylie for research assistance, David Johnson MD for statistical analysis, as well as all the families who volunteered to participate in this study. This project was funded by the Jonty Foundation, Minnesota, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robertson, M.A., Sigalet, D.L., Holst, J.J. et al. Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study. J Autism Dev Disord 38, 1066–1071 (2008). https://doi.org/10.1007/s10803-007-0482-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-007-0482-1